AU6129300A - Synthesis of carbamate ketolide antibiotics - Google Patents

Synthesis of carbamate ketolide antibiotics Download PDF

Info

Publication number
AU6129300A
AU6129300A AU61293/00A AU6129300A AU6129300A AU 6129300 A AU6129300 A AU 6129300A AU 61293/00 A AU61293/00 A AU 61293/00A AU 6129300 A AU6129300 A AU 6129300A AU 6129300 A AU6129300 A AU 6129300A
Authority
AU
Australia
Prior art keywords
alkyl
groups
group
substituted
optionally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU61293/00A
Other languages
English (en)
Inventor
Takushi Kaneko
Robert William Mclaughlin
William Thomas Mcmillen
David Harold Brown Ripin
Brian Clement Vanderplas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Products Inc
Original Assignee
Pfizer Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc filed Critical Pfizer Products Inc
Publication of AU6129300A publication Critical patent/AU6129300A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AU61293/00A 1999-09-29 2000-09-25 Synthesis of carbamate ketolide antibiotics Abandoned AU6129300A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15655499P 1999-09-29 1999-09-29
US60156554 1999-09-29

Publications (1)

Publication Number Publication Date
AU6129300A true AU6129300A (en) 2001-04-05

Family

ID=22560054

Family Applications (1)

Application Number Title Priority Date Filing Date
AU61293/00A Abandoned AU6129300A (en) 1999-09-29 2000-09-25 Synthesis of carbamate ketolide antibiotics

Country Status (18)

Country Link
EP (1) EP1088828A3 (enExample)
JP (1) JP2001151792A (enExample)
KR (1) KR20010050704A (enExample)
CN (1) CN1289778A (enExample)
AR (1) AR023273A1 (enExample)
AU (1) AU6129300A (enExample)
BR (1) BR0004537A (enExample)
CA (1) CA2321336C (enExample)
CZ (1) CZ20003567A3 (enExample)
HU (1) HUP0003834A3 (enExample)
ID (1) ID27331A (enExample)
IL (1) IL138633A0 (enExample)
IN (2) IN187119B (enExample)
PL (1) PL342917A1 (enExample)
RU (1) RU2188827C2 (enExample)
TR (1) TR200002787A2 (enExample)
YU (1) YU57900A (enExample)
ZA (1) ZA200005139B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040005641A1 (en) 2002-02-15 2004-01-08 Michael Burnet Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
AU2003211113B2 (en) 2002-02-15 2007-08-09 Merckle Gmbh Antibiotic conjugates
EP1483277A4 (en) 2002-02-15 2007-10-03 Merckle Gmbh CONJUGATES OF BIOLOGICALLY ACTIVE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND USE, FORMULATION AND PHARMACEUTICAL APPLICATIONS THEREOF
CN102199180B (zh) * 2011-04-12 2014-07-09 连云港杰瑞药业有限公司 一种卡培他滨的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
ES2087737T3 (es) * 1992-04-22 1996-07-16 Taisho Pharmaceutical Co Ltd Un derivado 5-o-desosaminil-eritronoluro a.
FR2727969B1 (fr) * 1994-12-09 1997-01-17 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2760017B1 (fr) * 1997-02-27 1999-04-30 Hoechst Marion Roussel Inc Nouveaux derives de l'erytromycine, leur procede de preparation et leur application comme medicaments
KR20010013660A (ko) * 1997-06-11 2001-02-26 실버스타인 아써 에이. 9-옥심 에리트로마이신 유도체
HN1998000159A (es) * 1997-10-29 1999-02-09 Monsanto Co Derivados de 9- amino - 3 ceto eritromicina
AP1060A (en) * 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.

Also Published As

Publication number Publication date
CA2321336C (en) 2005-03-15
YU57900A (sh) 2003-02-28
IN188930B (enExample) 2002-11-23
CA2321336A1 (en) 2001-03-29
CN1289778A (zh) 2001-04-04
TR200002787A2 (tr) 2001-04-20
KR20010050704A (ko) 2001-06-15
ID27331A (id) 2001-03-29
EP1088828A3 (en) 2001-04-11
HU0003834D0 (en) 2000-09-28
JP2001151792A (ja) 2001-06-05
RU2188827C2 (ru) 2002-09-10
PL342917A1 (en) 2001-04-09
CZ20003567A3 (cs) 2002-01-16
ZA200005139B (en) 2002-03-26
HUP0003834A3 (en) 2001-07-30
AR023273A1 (es) 2002-09-04
HUP0003834A2 (hu) 2001-05-28
IL138633A0 (en) 2001-10-31
EP1088828A2 (en) 2001-04-04
BR0004537A (pt) 2001-04-17
IN187119B (enExample) 2002-02-09

Similar Documents

Publication Publication Date Title
AU2001260537B2 (en) 2-aminocarbonyl-9H-purine derivatives
KR102022715B1 (ko) 핵 수송 조절인자 및 이의 용도
JP4589110B2 (ja) 抗炎症性活性を有するマクロライド化合物
KR20250123932A (ko) Wrn 억제제
FI108723B (fi) Menetelmä terapeuttisesti käyttökelpoisten 4a,5,9,10,11,12-heksahydro-11-metyyli-6H-bentsofuro[3a,3,2-ef][2]bentsatsepiini-3,6-diolin 6-esterijohdannaisten valmistamiseksi
AU2022212854B2 (en) Toxin molecule suitable for antibody-drug conjugate
JPS63275598A (ja) デスアザプリン―ヌクレオシド―誘導体
EP0269025A2 (en) Rebeccamycin analogs
JPH07508718A (ja) Ａ↓２アゴニスト活性を有するアデノシン誘導体
WO2005012323A2 (en) Compounds useful as a3 adenosine receptor agonists
EP2077271A1 (en) Macrolide derivative
ZA200301047B (en) New macrolides with antibacterial activity.
ZA200505040B (en) Process for the production of 3'-nucleoside prodrus
RS57900B1 (sr) Postupci i reagensi za održavanje u životu ćelija kancera u hirurški uklonjenom tkivu
KR20000011071A (ko) 3-데스클라디노스-2,3-안하이드로에리트로마이신 유도체
SK692004A3 (en) Pyrido-pyrido-pyrrolo pyrrolo-indole and pyrido-pyrrolo pyrrolo carbazole derivatives, method for the production thereof and pharmaceutical compositions containing said derivatives
US3721664A (en) Preparation of 5-cytosine nucleosides
AU2004232392A1 (en) (Purin-6-yl) amino acid and production method thereof
CA2321336C (en) Synthesis of carbamate ketolide antibiotics
RU2441876C2 (ru) Производное 3'-этинилцитидина
SK13972000A3 (sk) Makrolidové zlúčeniny pôsobiace ako antagonisty lhrh
US6403776B1 (en) Synthesis of carbamate ketolide antibiotics
WO2001077134A2 (en) Process for the preparation of 6-o-propargyl erythromycin derivatives
JP2007500193A (ja) 新規な１４−及び１５−員環化合物
MXPA00009540A (en) Synthesis of carbamate ketolide antibiotics